Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

AVID study results reported

Dec. 1, 1997

Pharmacological profile and antihypertensive effects of YM-358

Dec. 1, 1997

Bayer focuses on agents for atherosclerosis

Dec. 1, 1997

Antiproliferative effects of new tyrosine kinase inhibitor CGP-53716

Nov. 28, 1997

KRN-4884: mechanism of action of new KATP channel opener

Nov. 28, 1997

Bayer patents new antiatherosclerotic agents

Nov. 28, 1997

Pharmacological profile of TH-142177, a new AT1 receptor antagonist

Nov. 27, 1997

New V1 antagonists disclosed by Yamanouchi

Nov. 27, 1997

Takeda develops potassium channel openers for cardiovascular indications

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...